Chinese Reverse-Merger’s Auditor Resigns, Shares Fall 18%.

Yesterday Yuhe International, Inc. (NASDAQ: YUII) announced that Grant Thornton “is resigning as the Company’s independent registered public accounting firm effective immediately,” according to an 8-K filed by Yuhe. Yuhe’s share-price fell 18% yesterday.

Yuhe is the product of a reverse merger between a private Chinese company and a U.S. shell company completed in March 2008. Yuhe has been listed on the NASDAQ since October 30, 2009, according to a Yuhe 8-K dated October 29, 2009. Yuhe’s management and promoters rang NASDAQ’s opening bell on December 30, 2009.

Research published by asensio.com has focused on two other Chinese reverse-mergers: China Sky One Medical, Inc. (NASDAQ: CSKI) and American Oriental Bioengineering, Inc. (NYSE: AOB). asensio.com has also published reports on regulatory deficiencies surrounding U.S. listings of questionable Chinese companies, particularly at the NASDAQ.

On March 10th, asensio.com published a report questioning whether CSKI’s auditor, Moore Stephens, P.C., would resign as a result of a lawsuit brought against it for securities fraud related to CSKI’s financial statements.

Yuhe has the same investor-relations representative as CSKI, Crocker Coulson of CCG Investor Relations.

Grant Thornton’s resignation as Yuhe’s auditor surrounds “certain related party loans” that “have constituted prohibited transactions under Section 402 of the Sarbanes-Oxley Act of 2002,” according to Yuhe’s 8-K filed yesterday.

The 8-K states, “Grant Thornton noted during its audit procedures that the Company has been unable to eliminate the occurrence of related party loans… The Company concluded that a material weakness continues to exist with respect to the Company’s compliance with Section 402 of the Sarbanes-Oxley Act of 2002.”

Grant Thornton had only been appointed as Yuhe’s auditor on December 8, 2009. Yuhe’s previous auditor, Child, Van Wagoner & Bradshaw, PLLC of Salt Lake City, Utah and Hong Kong, has now been reappointed.

Posted in China Sky One Medical, Inc.

Manuel Asensio doesn’t bet often. But when he does, it’s wise to pay attention.

Paul Kaihla
eCompany Now
1 2 3 4 5 6 7 8 9
About Our Founder
Learn more about asensio.com's founder, Manuel P. Asensio, and the website's origins. Click here to be directed to Mr. Asensio’s professional biography.
Media Record
Click here to see selected articles that discuss asensio.com's work and its unique legacy. asensio.com also strives to maintain a complete record of articles dealing with the companies that are the subject of asensio.com research.
Investment Record
Click here to view a list of the companies that have been subjects of asensio.com reporting and click here to see the complete investment record.
Asensio and FINRA
Asensio & Company, Inc. and Manuel P. Asensio are the only dedicated short sellers ever to have been members of FINRA. This unique-minority membership created complications in the regulatory relationship. Being the first activist short investors and among the first FINRA member firms with a website added to the complexity. A statement by Mr. Asensio is available here. Information necessary to obtain a meaningful understanding of the dispute is available in complete form HERE.